| PERIOD ENDING | 31-Oct-09 | 31-Jul-09 | 30-Apr-09 | 31-Jan-09 | | Total Revenue | 502,552 | 440,924 | 415,472 | 226,683 | | Cost of Revenue | 432,781 | 383,054 | 369,025 | 218,526 | | | Gross Profit | 69,771 | 57,870 | 46,447 | 8,157 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 34,767 | 25,942 | 33,971 | 30,199 | | Non Recurring |
-
|
-
| 7,864 | 2,044 | | Others | 91 | 476 |
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 34,913 | 31,452 | 4,612 | (24,086) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 2,439 | 2,211 | 104 | 1,247 | | Earnings Before Interest And Taxes | 37,352 | 33,663 | 4,716 | (22,839) | | Interest Expense | 99 | 139 | 144 | 112 | | Income Before Tax | 37,253 | 33,524 | 4,572 | (22,951) | | Income Tax Expense | 13,824 | 8,743 | 2,470 | (8,091) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 23,429 | 24,781 | 2,102 | (14,860) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 23,429 | 24,781 | 2,102 | (14,860) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $23,429 | $24,781 | $2,102 | ($14,860) |
|
0.51% Nasdaq 0.00%
Income Statement
